Does NELARABINE Cause Bronchopulmonary aspergillosis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Bronchopulmonary aspergillosis have been filed in association with NELARABINE (Nelarabine). This represents 1.5% of all adverse event reports for NELARABINE.
11
Reports of Bronchopulmonary aspergillosis with NELARABINE
1.5%
of all NELARABINE reports
2
Deaths
6
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From NELARABINE?
Of the 11 reports, 2 (18.2%) resulted in death, 6 (54.5%) required hospitalization, and 9 (81.8%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELARABINE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NELARABINE Cause?
Febrile neutropenia (67)
Drug ineffective (50)
Myelopathy (47)
Neurotoxicity (47)
Neuropathy peripheral (45)
Muscular weakness (42)
Sepsis (39)
Peripheral sensory neuropathy (38)
Neutropenia (37)
Off label use (37)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which NELARABINE Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
NELARABINE vs NELFINAVIR
NELARABINE vs NELVUTAMIG
NELARABINE vs NEMOLIZUMAB
NELARABINE vs NEMOLIZUMAB-ILTO
NELARABINE vs NEOMYCIN